HCID 11998771, compound → HCID 86607427, compound
Reaction equation
[F:1][C:2]([F:47])([F:46])[CH2:3][C:4]([N:6]([CH2:8][C@@:9]([N:36]([CH3:45])[C:37](=[O:44])[C:38]1[CH:43]=[CH:42][CH:41]=[CH:40][CH:39]=1)([C:28]1[CH:33]=[CH:32][C:31]([Cl:34])=[C:30]([Cl:35])[CH:29]=1)[CH2:10][CH2:11][N:12]1[CH2:17][CH2:16][C:15]2([C:26]3[C:21](=[CH:22][CH:23]=[CH:24][CH:25]=3)[CH2:20][C:19](=[O:27])[NH:18]2)[CH2:14][CH2:13]1)[CH3:7])=[O:5].Cl.O1CCOCC1>C(Cl)(Cl)Cl>[ClH:34].[F:46][C:2]([F:1])([F:47])[CH2:3][C:4]([N:6]([CH2:8][C@@:9]([N:36]([CH3:45])[C:37](=[O:44])[C:38]1[CH:39]=[CH:40][CH:41]=[CH:42][CH:43]=1)([C:28]1[CH:33]=[CH:32][C:31]([Cl:34])=[C:30]([Cl:35])[CH:29]=1)[CH2:10][CH2:11][N:12]1[CH2:13][CH2:14][C:15]2([C:26]3[C:21](=[CH:22][CH:23]=[CH:24][CH:25]=3)[CH2:20][C:19](=[O:27])[NH:18]2)[CH2:16][CH2:17]1)[CH3:7])=[O:5]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
N-{1-(3,3,3-Trifluoro-N-methylpropanamido)-2-(S)-(3,4-dichlorophenyl)-4-[3-oxo-3,4-dihydro-2H-spiro(isoquinoline-1,4′-piperidin)-1′-yl]butan-2-yl}-N-methylbenzamide (442 mg) was dissolved in chloroform, and 4N HCl-1,4-dioxane (160 μL) was added thereto. The solvent was concentrated under reduced pressure. Ether was added to the residue, followed by filtration and drying, to thereby give the title compound (391 mg, 84.0%) as white powder.
Workup
- concentrationThe solvent was concentrated under reduced pressure
- additionEther was added to the residue
- filtrationfollowed by filtration
- customdrying
Sources & evidence
- ORD record
- ord-e7fb8d8bcba945269bbc6bcb9b515281
- Source dataset
- uspto-grants-2007_10
- Patent number
- US07276511B2
Reaction notes
Loading…